nasal decongestants

Preferred Label : nasal decongestants;

MeSH definition : Drugs designed to treat inflammation of the nasal passages, generally the result of an infection (more often than not the common cold) or an allergy related condition, e.g., hay fever. The inflammation involves swelling of the mucous membrane that lines the nasal passages and results in inordinate mucus production. The primary class of nasal decongestants are vasoconstrictor agents. (From PharmAssist, The Family Guide to Health and Medicine, 1993);

MeSH synonym : decongestants, nasal; Nasal Decongestant; Decongestant, Nasal;

MeSH Hyperonym : decongestants; Decongestant;

MeSH hyponym : vasoconstrictor agents, nasal; Agents, Nasal Vasoconstrictor; Nasal Vasoconstrictor Agents; Vasoconstrictors, Nasal; Nasal Vasoconstrictors;

MeSH annotation : Nasal Decongestants - do not use entry term VASOCONSTRICTOR AGENTS, NASAL for the nasal administration of systemic vasoconstrictor agents; use instead the specific vasoconstrictor agent / admin ADMINISTRATION, INTRANASAL;

Wikipedia link : https://en.wikipedia.org/wiki/Decongestants;

Is substance : O;

action pharmacologique : O;

Details

Origin ID

D014663;

UMLS CUI

C0042398;

ATC code(s)
- decongestants and other nasal preparations for topical use [ATC Code]
- naphazoline [ATC Code]
- nasal decongestants for systemic use [ATC Code]
- oxymetazoline [ATC Code]
- phenylephrine [ATC Code]
- phenylephrine, combinations [ATC Code]
- phenylpropanolamine [ATC Code]
- phenylpropanolamine, combinations [ATC Code]
- pseudoephedrine [ATC Code]
- pseudoephedrine, combinations [ATC Code]
- tetryzoline [ATC Code]
- tramazoline [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Decongestant (substance) [SNOMED CT concept]
- Medicinal product acting as decongestant (product) [SNOMED CT concept]
- decongestant preparation, nos [SNOMED Notion]
CISMeF manual mappings
- Decongestant, nasal (mucosa) [ICD-11 Extension code]
Manual BTNT mappings - CISMeF
- Decongestant, nasal combination [ICD-11 Extension code]
MedlinePlus topic(s)
- cold and cough medicines [MedlinePlus Topic]
Metaterm(s)
- otolaryngology [CISMeF Metaterm]
Record concept(s)
- decongestants [MeSH concept]
- nasal decongestants [MeSH concept]
- vasoconstrictor agents, nasal [MeSH concept]
Semantic type(s)
- Pharmacologic Substance [UMLS semantic type]
Substance(s)
- brompheniramine, pseudoephedrine drug combination [MeSH Supplementary Concept]
- cirazoline [MeSH Supplementary Concept]
- naphazoline [MeSH Descriptor]
- oxymetazoline [MeSH Descriptor]
- phenylephrine [MeSH Descriptor]
- phenylpropanolamine [MeSH Descriptor]
- pseudoephedrine [MeSH Descriptor]
- synephrine [MeSH Descriptor]
- tetrahydrozoline [MeSH Supplementary Concept]
- xylometazoline [MeSH Supplementary Concept]
UMLS correspondences (same concept)
- Decongestant, nasal (mucosa) [ICD-11 Extension code]
- Nasal decongestant preparation (product) [Inactive SNOMED CT concept]
- nasal decongestant preparation, nos [SNOMED Notion]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients